Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COMT Inhibition as a Novel Treatment for Nicotine Addiction in Women

NCT02448654 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT02448654
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02448654 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COMT Inhibition as a Novel Treatment for Nicotine Addiction in Women
Lead sponsor
Yale University
Phase
Not applicable
Overall status
Completed
Start date
October 23, 2015
Completion date
June 30, 2019
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nicotine dependence